Niharika B. Mettu, MD, PhD | Authors

Use of Molecular Biomarkers to Inform Adjuvant Therapy for Colon Cancer

August 15, 2013

In this review, we will discuss adjuvant chemotherapy in non-metastatic colon cancer, the existing prognostic and predictive molecular biomarkers in the field, and how to integrate these molecular biomarkers into the decision about whether to administer adjuvant therapy.